Literature DB >> 26221296

MicroRNA-H4-5p encoded by HSV-1 latency-associated transcript promotes cell proliferation, invasion and cell cycle progression via p16-mediated PI3K-Akt signaling pathway in SHSY5Y cells.

Huiliang Zhao1, Chunying Zhang2, Guangjun Hou2, Jijun Song3.   

Abstract

Herpes simplex virus 1 (HSV-1) microRNAs (miRNAs) mostly located in transcription-associated transcript (LAT) region have been identified that play critical roles in the intricate host-pathogen interaction networks. Increasing evidences throw new insight into the role of miRNA-mediated miRNA-mRNA cross-talk in HSV-1 latent or acute infection. In the present study, we found that hsv-1 miR-H4-5p (here termed as miR-H4b) can down-regulate the expression of cyclin-dependent kinase inhibitor 2A (CDKN2A, p16) in neuroblastoma (SHSY5Y) cell lines. Decreased expression of miR-H4b was directly related to attenuated cell proliferation and invasion as well as malfunction of cell cycle in recombinant SHSY5Y cells that stably expressing miR-H4b. Bioinformatics analysis and luciferase assays demonstrated miR-H4b can directly target p16 mRNA. MiR-H4b exerts its pro-proliferation function through inhibition of the p16-related PI3K-Akt pathways. Our findings provide, for the first time, significant clues regarding the role of herpesvirus-encoded miRNAs as a viral modulator to host cells.

Entities:  

Keywords:  Viral microRNA; host-pathogen interaction; p16

Year:  2015        PMID: 26221296      PMCID: PMC4509241     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

1.  Evidence that the nonsense-mediated mRNA decay pathway participates in X chromosome dosage compensation in mammals.

Authors:  Shanye Yin; Wenjun Deng; Hancheng Zheng; Zhengguo Zhang; Landian Hu; Xiangyin Kong
Journal:  Biochem Biophys Res Commun       Date:  2009-04-11       Impact factor: 3.575

Review 2.  PI3K/AKT/mTOR pathway inhibitors: the ideal combination partners for breast cancer therapies?

Authors:  Jame Abraham
Journal:  Expert Rev Anticancer Ther       Date:  2014-10-11       Impact factor: 4.512

3.  CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury.

Authors:  Derek P DiRocco; John Bisi; Patrick Roberts; Jay Strum; Kwok-Kin Wong; Norman Sharpless; Benjamin D Humphreys
Journal:  Am J Physiol Renal Physiol       Date:  2013-12-11

4.  The PI3K/mTOR dual inhibitor NVP-BEZ235 reduces the growth of ovarian clear cell carcinoma.

Authors:  Tetsuro Oishi; Hiroaki Itamochi; Akiko Kudoh; Michiko Nonaka; Misaki Kato; Mayumi Nishimura; Nao Oumi; Seiya Sato; Jun Naniwa; Shinya Sato; Muneaki Shimada; Junzo Kigawa; Tasuku Harada
Journal:  Oncol Rep       Date:  2014-06-13       Impact factor: 3.906

5.  Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2.

Authors:  Igor Jurak; Martha F Kramer; Joseph C Mellor; Alison L van Lint; Frederick P Roth; David M Knipe; Donald M Coen
Journal:  J Virol       Date:  2010-02-24       Impact factor: 5.103

6.  IRE1α-TRAF2-ASK1 complex-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to CXC195-induced apoptosis in human bladder carcinoma T24 cells.

Authors:  Tao Zeng; Lifen Peng; Haichao Chao; Haibo Xi; Bin Fu; Yibing Wang; Zunwei Zhu; Gongxian Wang
Journal:  Biochem Biophys Res Commun       Date:  2015-03-19       Impact factor: 3.575

7.  Latency-associated transcript (LAT) exon 1 controls herpes simplex virus species-specific phenotypes: reactivation in the guinea pig genital model and neuron subtype-specific latent expression of LAT.

Authors:  Andrea S Bertke; Amita Patel; Yumi Imai; Kathleen Apakupakul; Todd P Margolis; Philip R Krause
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

8.  CDKN2A mutations could influence the dermoscopic pattern of presentation of multiple primary melanoma: a clinical dermoscopic genetic study.

Authors:  V De Giorgi; I Savarese; A D'Errico; A Gori; F Papi; M Colombino; M Cristina Sini; I Stanganelli; G Palmieri; D Massi
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-09-08       Impact factor: 6.166

Review 9.  Host-virus interaction: a new role for microRNAs.

Authors:  Vinod Scaria; Manoj Hariharan; Souvik Maiti; Beena Pillai; Samir K Brahmachari
Journal:  Retrovirology       Date:  2006-10-11       Impact factor: 4.602

10.  CDKN2A gene inactivation in epithelial sporadic ovarian cancer.

Authors:  D Niederacher; H Y Yan; H X An; H G Bender; M W Beckmann
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

View more
  6 in total

1.  Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide.

Authors:  Alena Cristina Jaime-Ramirez; Nina Dmitrieva; Ji Young Yoo; Yeshavanth Banasavadi-Siddegowda; Jianying Zhang; Theresa Relation; Chelsea Bolyard; Jeffrey Wojton; Balveen Kaur
Journal:  J Gene Med       Date:  2017-03       Impact factor: 4.565

2.  Effect of Loss-of-function of the Herpes Simplex Virus-1 microRNA H6-5p on Virus Replication.

Authors:  Rongquan Huang; Xusha Zhou; Shuqi Ren; Xianjie Liu; Zhiyuan Han; Grace Guoying Zhou
Journal:  Virol Sin       Date:  2019-04-24       Impact factor: 4.327

3.  miR-H28 and miR-H29 expressed late in productive infection are exported and restrict HSV-1 replication and spread in recipient cells.

Authors:  Zhiyuan Han; Xianjie Liu; Xiaoqing Chen; Xusha Zhou; Te Du; Bernard Roizman; Guoying Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

Review 4.  The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets.

Authors:  Shaohui Huang; Naying Gong; Jiangbin Li; Mingye Hong; Li Li; Ling Zhang; Hua Zhang
Journal:  Biomark Res       Date:  2022-04-07

Review 5.  Herpesviral microRNAs in Cellular Metabolism and Immune Responses.

Authors:  Hyoji Kim; Hisashi Iizasa; Yuichi Kanehiro; Sintayehu Fekadu; Hironori Yoshiyama
Journal:  Front Microbiol       Date:  2017-07-18       Impact factor: 5.640

Review 6.  MicroRNA Involvement in Signaling Pathways During Viral Infection.

Authors:  Madalina Gabriela Barbu; Carmen Elena Condrat; Dana Claudia Thompson; Oana Larisa Bugnar; Dragos Cretoiu; Oana Daniela Toader; Nicolae Suciu; Silviu Cristian Voinea
Journal:  Front Cell Dev Biol       Date:  2020-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.